These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38190116)

  • 1. Facts and Hopes on Chimeric Cytokine Agents for Cancer Immunotherapy.
    Ren Z; Zhang X; Fu YX
    Clin Cancer Res; 2024 May; 30(10):2025-2038. PubMed ID: 38190116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-cytokine fusion proteins for the therapy of cancer.
    Helguera G; Penichet ML
    Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy.
    Mortara L; Balza E; Bruno A; Poggi A; Orecchia P; Carnemolla B
    Front Immunol; 2018; 9():2905. PubMed ID: 30619269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.
    Leonard EK; Tomala J; Gould JR; Leff MI; Lin JX; Li P; Porter MJ; Johansen ER; Thompson L; Cao SD; Hou S; Henclova T; Huliciak M; Sargunas PR; Fabilane CS; Vaněk O; Kovar M; Schneider B; Raimondi G; Leonard WJ; Spangler JB
    JCI Insight; 2024 Sep; 9(18):. PubMed ID: 39115939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.
    Young PA; Morrison SL; Timmerman JM
    Semin Oncol; 2014 Oct; 41(5):623-36. PubMed ID: 25440607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity.
    Fournier P; Aigner M; Schirrmacher V
    Int J Oncol; 2011 Jun; 38(6):1719-29. PubMed ID: 21424118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity.
    Shen S; Sckisel G; Sahoo A; Lalani A; Otter DD; Pearson J; DeVoss J; Cheng J; Casey SC; Case R; Yang M; Low R; Daris M; Fan B; Agrawal NJ; Ali K
    Front Immunol; 2020; 11():832. PubMed ID: 32457754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-cytokine fusion proteins for cancer immunotherapy: an update on recent developments.
    Müller D
    BioDrugs; 2014 Apr; 28(2):123-31. PubMed ID: 24018469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines in clinical cancer immunotherapy.
    Berraondo P; Sanmamed MF; Ochoa MC; Etxeberria I; Aznar MA; Pérez-Gracia JL; Rodríguez-Ruiz ME; Ponz-Sarvise M; Castañón E; Melero I
    Br J Cancer; 2019 Jan; 120(1):6-15. PubMed ID: 30413827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity.
    Neri D
    Cancer Immunol Res; 2019 Mar; 7(3):348-354. PubMed ID: 30824549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
    Dhupkar P; Gordon N
    Adv Exp Med Biol; 2017; 995():33-51. PubMed ID: 28321811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells.
    Xu XJ; Tang YM
    Cancer Lett; 2014 Feb; 343(2):172-8. PubMed ID: 24141191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-cytokine fusion proteins for the therapy of cancer.
    Penichet ML; Morrison SL
    J Immunol Methods; 2001 Feb; 248(1-2):91-101. PubMed ID: 11223071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody fusions with immunomodulatory proteins for cancer therapy.
    Müller D
    Pharmacol Ther; 2015 Oct; 154():57-66. PubMed ID: 26145167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of interleukin-2 therapy in cancer.
    Tartour E; Mathiot C; Fridman WH
    Biomed Pharmacother; 1992; 46(10):473-84. PubMed ID: 1306361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy.
    Valedkarimi Z; Nasiri H; Aghebati-Maleki L; Majidi J
    Biomed Pharmacother; 2017 Nov; 95():731-742. PubMed ID: 28888210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity.
    Xu Y; Carrascosa LC; Yeung YA; Chu ML; Yang W; Djuretic I; Pappas DC; Zeytounian J; Ge Z; de Ruiter V; Starbeck-Miller GR; Patterson J; Rigas D; Chen SH; Kraynov E; Boor PP; Noordam L; Doukas M; Tsao D; Ijzermans JN; Guo J; Grünhagen DJ; Erdmann J; Verheij J; van Royen ME; Doornebosch PG; Feldman R; Park T; Mahmoudi S; Dorywalska M; Ni I; Chin SM; Mistry T; Mosyak L; Lin L; Ching KA; Lindquist KC; Ji C; Londono LM; Kuang B; Rickert R; Kwekkeboom J; Sprengers D; Huang TH; Chaparro-Riggers J
    Cancer Immunol Res; 2021 Oct; 9(10):1141-1157. PubMed ID: 34376502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted cytokines for cancer immunotherapy.
    Lode HN; Reisfeld RA
    Immunol Res; 2000; 21(2-3):279-88. PubMed ID: 10852128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.